Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Efstathiou

Showing results (51-60 of 278) with videos related to

Pageof 28
Sort By:
Cancer Treatment Reviews|November 30, 2023
Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancerJason A Efstathiou, Alicia K Morgans, Christopher S Bland, et al.
Clinical Genitourinary Cancer|January 3, 2015
National trends in the recommendation of radiotherapy after prostatectomy for prostate cancer before and after the reporting of a survival benefit in March 2009Brandon A Mahal, Karen E Hoffman, Jason A Efstathiou, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Global Radiation Oncology From the Trainee Perspective: A View From Beyond the BunkerShekinah N Elmore, Roshan V Sethi, Akila N Viswanathan, et al.
European Urology|September 9, 2019
Recent Global Patterns in Prostate Cancer Incidence and Mortality RatesMaryBeth B Culp, Isabelle Soerjomataram, Jason A Efstathiou, et al.
Nature Reviews. Clinical Oncology|March 2, 2010
Hormonal therapies: ADT for prostate cancer: true love or heartbreak?Jason A Efstathiou, William U Shipley, Anthony L Zietman, et al.
European Urology Focus|July 21, 2017
The Natural History and Outcome Predictors of Metastatic Castration-resistant Prostate CancerRobert J van Soest, Jason A Efstathiou, Cora N Sternberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 16, 2013
Trimodality bladder preservation therapy for muscle-invasive bladder cancerRonald C Chen, William U Shipley, Jason A Efstathiou, et al.
International Journal of Radiation Oncology, Biology, Physics|March 23, 2012
Radiotherapy treatment planning for testicular seminomaRichard B Wilder, Mark K Buyyounouski, Jason A Efstathiou, et al.
Current Opinion in Urology|July 16, 2013
Recent advances and the emerging role for chemoradiation in nonmuscle invasive bladder cancerPhillip J Gray, William U Shipley, Jason A Efstathiou, et al.
Cancer|September 16, 2015
Association of very low prostate-specific antigen levels with increased cancer-specific death in men with high-grade prostate cancerBrandon A Mahal, Ayal A Aizer, Jason A Efstathiou, et al.
Pageof 28

Showing results (51-60 of 278) with videos related to

Sort By:
Pageof 28
Cancer Treatment Reviews|November 30, 2023
Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancerJason A Efstathiou, Alicia K Morgans, Christopher S Bland, et al.
Clinical Genitourinary Cancer|January 3, 2015
National trends in the recommendation of radiotherapy after prostatectomy for prostate cancer before and after the reporting of a survival benefit in March 2009Brandon A Mahal, Karen E Hoffman, Jason A Efstathiou, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Global Radiation Oncology From the Trainee Perspective: A View From Beyond the BunkerShekinah N Elmore, Roshan V Sethi, Akila N Viswanathan, et al.
European Urology|September 9, 2019
Recent Global Patterns in Prostate Cancer Incidence and Mortality RatesMaryBeth B Culp, Isabelle Soerjomataram, Jason A Efstathiou, et al.
Nature Reviews. Clinical Oncology|March 2, 2010
Hormonal therapies: ADT for prostate cancer: true love or heartbreak?Jason A Efstathiou, William U Shipley, Anthony L Zietman, et al.
European Urology Focus|July 21, 2017
The Natural History and Outcome Predictors of Metastatic Castration-resistant Prostate CancerRobert J van Soest, Jason A Efstathiou, Cora N Sternberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 16, 2013
Trimodality bladder preservation therapy for muscle-invasive bladder cancerRonald C Chen, William U Shipley, Jason A Efstathiou, et al.
International Journal of Radiation Oncology, Biology, Physics|March 23, 2012
Radiotherapy treatment planning for testicular seminomaRichard B Wilder, Mark K Buyyounouski, Jason A Efstathiou, et al.
Current Opinion in Urology|July 16, 2013
Recent advances and the emerging role for chemoradiation in nonmuscle invasive bladder cancerPhillip J Gray, William U Shipley, Jason A Efstathiou, et al.
Cancer|September 16, 2015
Association of very low prostate-specific antigen levels with increased cancer-specific death in men with high-grade prostate cancerBrandon A Mahal, Ayal A Aizer, Jason A Efstathiou, et al.
Pageof 28